MedPath

The effect of water-based exercise in chronic obstructive pulmonary disease

Phase 1
Completed
Conditions
Chronic obstructive pulmonary disease
Respiratory - Chronic obstructive pulmonary disease
Registration Number
ACTRN12606000408583
Lead Sponsor
Prince of Wales Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
45
Inclusion Criteria

Confirmed diagnosis of chronic obstructive pulmonary disease; stable condition; presence of one or more co-morbid conditions (BMI> or equal to 32, musculoskeletal conditions affecting the lumbar spine or lower limbs, neurolocical conditions, neuromuscular disorders and one or more lower-limb joint replacements restricting mobility and/or joint range of motion). Both male and female subjects will be included with no age limits as long as the inclusion crieria are met.

Exclusion Criteria

Unstable cardiac disease, contra-indications to aquatic therapy, completed a pulmonary rehabilitation program in the last 12 months or attending maintenance exercise, inability to understand English, cognitive decline.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Functional exercise capacity measured by six-minute walk test, incremental shuttle walk test, endurance shuttle walk test. [At baseline and at 8 weeks.];Quality of life measured by St George Respiratory Questionnaire, SF-36 and Chronic Respiratory Disease Questionnaire.[At baseline and at 8 weeks.]
Secondary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression Scale[Measured at initial assessment and at completion of the 8 weeks intervention or usual care.];Lung function[Measured at initial assessment and at completion of the 8 weeks intervention or usual care.];respiratory muscle strength.[Measured at initial assessment and at completion of the 8 weeks intervention or usual care.];Acceptability of water-based training[At the completion of the 8 weeks intervention];Compliance[At the completion of the 8 weeks intervention]
© Copyright 2025. All Rights Reserved by MedPath